Simultaneous transcatheter edge-to-edge repair (TEER) for severe mitral and tricuspid regurgitation is feasible, safe, and associated with good clinical outcome
Combined MR/TR TEER is safe and reduces MR and TR in most patients, conferring a potential benefit regarding symptoms and prognosis. Randomized controlled trials (RCTs) are needed to rigorously evaluate combination therapy in this setting.
Authors
- Alexander Peikert (ORCID: https://orcid.org/0000-0003-0947-5865)
- Ewald Kolesnik (ORCID: https://orcid.org/0000-0002-9349-8068)
- Klemens Ablasser
- Andreas Zirlik (ORCID: https://orcid.org/0000-0001-6290-3297)
- Albrecht Schmidt (ORCID: https://orcid.org/0000-0003-4783-4603)
- Ivan Vosko (ORCID: https://orcid.org/0000-0002-6198-888X)
- Johannes Gollmer (ORCID: https://orcid.org/0000-0002-8734-6359)
- Birgit Zirngast (ORCID: https://orcid.org/0000-0002-6062-2210)
- Nicolas Verheyen (ORCID: https://orcid.org/0000-0001-7414-4056)
- Nora Schwegel (ORCID: https://orcid.org/0000-0001-8736-9625)
- Heiko Bugger (ORCID: https://orcid.org/0000-0002-3524-0405)
- Viktoria Santner (ORCID: https://orcid.org/0000-0001-8569-3683)
- Gábor G. Tóth (ORCID: https://orcid.org/0000-0002-0283-9091)
- Günther Laufer
- Wolfgang Marte
- Eva Buschmann
- Martin Andreas
- David Zweiker
Institutions
- Medical University of Graz (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-02-10
- DOI
- https://doi.org/10.1371/journal.pone.0339837
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00